Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective
-
Published:2023-12-19
Issue:1
Volume:16
Page:7
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Zhang Yun1ORCID, Wu Yongjia1ORCID, Du Hongjiang2, Li Zhiyong1, Bai Xiaofeng1, Wu Yange1, Li Huimin1, Zhou Mengqi1, Cao Yifeng3ORCID, Chen Xuepeng1
Affiliation:
1. Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Clinical Research Center for Oral Diseases of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou 310006, China 2. Department of Stomatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China 3. Department of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China
Abstract
Oral cancer (OC), characterized by malignant tumors in the mouth, is one of the most prevalent malignancies worldwide. Chemotherapy is a commonly used treatment for OC; however, it often leads to severe side effects on human bodies. In recent years, nanotechnology has emerged as a promising solution for managing OC using nanomaterials and nanoparticles (NPs). Nano-drug delivery systems (nano-DDSs) that employ various NPs as nanocarriers have been extensively developed to enhance current OC therapies by achieving controlled drug release and targeted drug delivery. Through searching and analyzing relevant research literature, it was found that certain nano-DDSs can improve the therapeutic effect of drugs by enhancing drug accumulation in tumor tissues. Furthermore, they can achieve targeted delivery and controlled release of drugs through adjustments in particle size, surface functionalization, and drug encapsulation technology of nano-DDSs. The application of nano-DDSs provides a new tool and strategy for OC therapy, offering personalized treatment options for OC patients by enhancing drug delivery, reducing toxic side effects, and improving therapeutic outcomes. However, the use of nano-DDSs in OC therapy still faces challenges such as toxicity, precise targeting, biodegradability, and satisfying drug-release kinetics. Overall, this review evaluates the potential and limitations of different nano-DDSs in OC therapy, focusing on their components, mechanisms of action, and laboratory therapeutic effects, aiming to provide insights into understanding, designing, and developing more effective and safer nano-DDSs. Future studies should focus on addressing these issues to further advance the application and development of nano-DDSs in OC therapy.
Funder
National Natural Science Foundation of China Zhejiang Provincial Natural Science Foundation of China the Key R&D Program of Zhejiang Cultivation of High-level Innovative Health Talents
Subject
Pharmaceutical Science
Reference197 articles.
1. Sachdeva, A., Dhawan, D., Jain, G.K., Yerer, M.B., Collignon, T.E., Tewari, D., and Bishayee, A. (2022). Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer. Cancers, 15. 2. Head and Neck Cancer in the New Era of Precision Medicine;Nor;J. Dent. Res.,2018 3. Yang, C.M., Chu, T.H., Tsai, K.W., Hsieh, S., and Kung, M.L. (2022). Phytochemically Derived Zingerone Nanoparticles Inhibit Cell Proliferation, Invasion and Metastasis in Human Oral Squamous Cell Carcinoma. Biomedicines, 10. 4. Chemopreventive and Anti-tumor Potential of Natural Products in Oral Cancer;Lafaurie;Nutr. Cancer,2022 5. Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer;Vyas;Nanomedicine,2023
|
|